Clinical Trials on Advanced Malignant Solid Tumor in New Zealand
Total 1683 results
-
Trans Tasman Radiation Oncology GroupUniversity Medical Center Groningen; Australian and New Zealand Intensive Care...CompletedLymph Node Disease | Malignant MelanomaAustralia, New Zealand, Netherlands, Brazil
-
Hoffmann-La RocheCompleted
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingLymphoma | Solid MalignancyUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompleted
-
Oxford BioTherapeutics LtdRecruitingSolid TumorUnited States, Belgium, Spain, France, Greece
-
Calgent Biotechnology Co., LtdCompletedResistant or Refractory Solid TumorsUnited States, Taiwan
-
Servier Bio-Innovation LLCInstitut de Recherches Internationales ServierRecruitingMTAP-deleted Solid TumorsAustralia, United States
-
Montefiore Medical CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Gary MorrowNational Cancer Institute (NCI)CompletedFatigue | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada
-
Columbia UniversityCompletedBreast Cancer | Locally Advanced Malignant NeoplasmUnited States
-
AbbVieCompletedAdvanced Solid Tumors CancerUnited States, Australia, France, Taiwan
-
CytomX TherapeuticsTerminatedSolid Tumor | Unresectable or Metastatic MelanomaKorea, Republic of, United States, Netherlands, Spain, Australia
-
Stanford UniversityAmgen; Pediatric Oncology Experimental Therapeutics Investigators' ConsortiumCompletedRefractory Leukemia | Refractory Solid Tumors | Relapsed Solid Tumors | Relapsed LeukemiaUnited States, Canada
-
Hoffmann-La RocheCompletedSolid TumorsHungary, United States, Korea, Republic of, Belgium, Germany, United Kingdom
-
AstraZenecaQuintiles, Inc.CompletedSolid TumorsUnited States, France, United Kingdom, Netherlands
-
Astellas Pharma IncRecruitingSolid TumorUnited States, Japan, France
-
XRad Therapeutics IncCompletedMetastasis | Recurrent Cancer | Locally Advanced Solid TumorUnited States
-
AstraZenecaCompletedSolid TumorsUnited States, France
-
Laminar PharmaceuticalsDana-Farber Cancer Institute; Hackensack Meridian Health; Laminar Pharma IncRecruitingHigh-grade Glioma | Solid Tumor, Unspecified, ChildUnited States
-
GlaxoSmithKlineNot yet recruitingSolid TumorsUnited States, Canada, Australia
-
SQZ BiotechnologiesTerminatedAdult Solid TumorUnited States
-
Memorial Sloan Kettering Cancer CenterPfizer; University of Wisconsin, Madison; Duke University; AEterna Zentaris; NATL...CompletedPediatric Solid TumorsUnited States
-
University of PittsburghNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Psychosocial Effects of Cancer and Its TreatmentUnited States
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited States, Germany, Italy, United Kingdom, Canada, France, Korea, Republic of, Netherlands
-
Novian Health Inc.Active, not recruitingMalignant TumorUnited States, United Kingdom
-
National Cancer Institute (NCI)CompletedLocally Advanced Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2 | Pancreatic Vipoma | Pancreatic Gastrinoma | Advanced Pancreatic Neuroendocrine TumorUnited States, Canada
-
H. Lee Moffitt Cancer Center and Research InstituteBayer; Pediatric Cancer FoundationCompleted
-
Abramson Cancer Center at Penn MedicineGuerbetActive, not recruitingLiver Metastases | Neuroendocrine Tumor, MalignantUnited States, Canada, Italy, Argentina
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); GlaxoSmithKline; Rutgers Cancer Institute of...TerminatedBreast Cancer - Female | Unspecified Adult Solid Tumor - Protocol SpecificUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Metastatic Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
BayerMerck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Spain, Germany, Switzerland, United Kingdom
-
Y-mAbs TherapeuticsTerminatedOsteosarcoma | Neuroblastoma | Other Solid Tumor CancersUnited States
-
FBD Biologics LimitedRecruitingAdvanced Solid Tumor | Refractory Non-Hodgkin LymphomaTaiwan, United States
-
National Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Hematopoietic and Lymphatic System NeoplasmUnited States
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Spain, Germany, France, Israel, Italy, United Kingdom
-
BioMed Valley Discoveries, IncCompletedSolid Tumor MalignanciesUnited States
-
BayerMerck Sharp & Dohme LLCCompletedAdvanced Solid Tumor | Head and Neck Squamous Cell CarcinomaUnited States
-
AstraZenecaActive, not recruitingLocally Advanced or Metastatic Solid TumoursUnited States, Spain, Canada, Korea, Republic of
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada, Australia
-
Novartis PharmaceuticalsCompletedEndometrial Cancer | VEGF | Solid Tumors and Advanced Endometrial Cancer | Second-line TreatmentItaly, United Kingdom, Spain, Brazil, United States, Korea, Republic of, New Zealand
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Australia
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingRelapsed or Refractory Solid TumorsUnited States, Argentina, Australia, Belgium, Croatia, Czechia, France, Guatemala, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Peru, Russian Federation, Serbia, South Africa, Spain, Sweden, Turkey
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, Spain, France, Italy, Korea, Republic of, Poland
-
Memorial Sloan Kettering Cancer CenterWashington University School of Medicine; University of California, Los Angeles and other collaboratorsTerminatedSarcoma | Leiomyosarcoma | Malignant Peripheral Nerve Sheath Tumor | Malignant Fibrous | Histiocytoma/Undifferentiated Pleomorphic SarcomaUnited States
-
PfizerRecruitingSolid TumorsUnited States, Spain, Canada, Italy, Australia, Hungary, Netherlands, United Kingdom, Germany, Brazil, Korea, Republic of, Portugal, France, Japan, Israel, Slovakia, Czechia
-
Novartis PharmaceuticalsCompletedSolid TumorsAustria, Belgium, United States, Italy, Denmark, Spain, Japan